-
BCECF-AM for Intracellular pH Measurement
2026-09-10
BCECF-AM turns dynamic intracellular acid–base changes into a quantitative ratiometric readout for mammalian, plant, microbial, and yeast experiments. This guide connects practical loading and calibration choices with secretion biology, cytotoxicity workflows, and troubleshooting strategies that improve cross-sample comparability.
-
Exogenous NADH Reprograms E. tarda Antibiotic Killing
2026-09-10
The 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism and markedly improve the bactericidal activity of neomycin and related antibiotics. By connecting purine and energy metabolism with ATP-dependent antibiotic efficacy, the work presents metabolic enhancement as an adjunct strategy for resistant bacterial infections.
-
AZD8055 Workflow for Dual mTOR Inhibition
2026-09-09
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolic responses. It is best suited to preclinical cell and animal workflows, not aqueous formulations or conclusions about clinical efficacy.
-
BMS-345541 (free base): Assay Reliability Guide
2026-09-09
Learn how BMS-345541 (free base), SKU B4655, can strengthen cell viability, inflammation, and NF-κB pathway experiments through mechanism-aware controls and practical handling. This guide connects biochemical potency, cell-based assay design, formulation, and vendor-selection criteria to improve interpretation and reproducibility.
-
EdU Imaging Kits (HF594) for PDAC PNI
2026-09-08
EdU Imaging Kits (HF594) convert S-phase DNA synthesis into a quantitative red-fluorescence readout for pancreatic cancer–Schwann cell models. This article translates the reference study’s PGE2-driven perineural invasion findings into practical imaging, flow cytometry, optimization, and troubleshooting workflows.
-
SHC-1 Inhibition and CFTR Membrane Trafficking
2026-09-08
The 2026 Biochemical and Biophysical Research Communications study shows that MAPK/SHC-1-dependent CFTR internalization occurs across airway and intestinal epithelial models, but that pharmacological responses to SHC-1 inhibitors are strongly cell-context dependent. Its findings refine how researchers interpret CFTR trafficking assays and suggest that increased surface abundance should be distinguished from selective restoration of channel regulation.
-
SM-102 for Reliable mRNA-LNP Cell Assays
2026-09-07
Learn how SM-102 (SKU C1042) can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows involving mRNA-loaded lipid nanoparticles. This scenario-based guide connects formulation identity, solvent compatibility, storage, controls, and vendor selection to evidence from recent mRNA delivery research.
-
XYD113: Selective GSPT1 Degradation in MYC Cancers
2026-09-07
The reference study identifies XYD113 as an orally active molecular glue degrader that selectively recruits CRBN to eliminate GSPT1 in MYC-driven cancer models. Its combination of sub-100 nM cellular antiproliferative activity, limited degradation of common glutarimide substrates, and xenograft efficacy supports further evaluation while leaving important translational questions unresolved.
-
Trelagliptin and PI-3K/AKT Signaling in Adipocytes
2026-09-05
The reference study shows that trelagliptin succinate can improve insulin resistance features in differentiated 3T3-L1 adipocytes by strengthening IRS-1/PI-3K/AKT signaling, GLUT4 membrane localization, and glucose uptake. Its findings extend the interpretation of DPP-4 inhibition beyond glycemic control by connecting trelagliptin with adipokine and lipid-related changes in an adipocyte model.
-
Resveratrol: SIRT1 Activator and Neuroprotection
2026-09-04
Resveratrol is a SIRT1 activator used to study mitochondrial quality control, apoptosis, oxidative stress, and inflammation. Evidence in prion-challenged N2a cells supports a SIRT1–PGC-1α–TFAM mechanism, while product data indicate dose-dependent effects in neuronal and rat cardiac models.
-
CCCP Workflows for Mitochondrial Imaging
2026-09-04
CCCP converts mitochondrial membrane-potential biology into a controlled experimental perturbation for live-cell imaging, morphology analysis, and assay validation. Paired with the urine-derived stem cell and deep-learning strategy reported in the reference study, it helps distinguish baseline disease-associated phenotypes from acute stress responses without overstating biomarker readiness.
-
RIPA Lysis Buffer for BBB Mechanism Translation
2026-09-03
A translational workflow for connecting astrocyte inflammation, blood-brain barrier integrity, and reproducible protein analysis. Using findings from a ginsenoside Rg2 Alzheimer’s disease model, this article explains how lysis chemistry, inhibitor strategy, and assay selection can strengthen mechanistic claims without overstating preclinical evidence.
-
CPSIT_0844 Activates TLR2/TLR4 Inflammation
2026-09-03
This 2026 study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory stimulus in human THP-1 monocytes. Its experiments connect CPSIT_0844 to TLR2/TLR4–MyD88 signaling and downstream JNK, p38, and NF-κB activation, clarifying how a pathogen-derived protein may contribute to inflammatory lung disease.
-
Tetracycline C6589 for Reliable Cell Assays
2026-09-02
Learn how Tetracycline (SKU C6589) can support controlled microbiological selection and cleaner interpretation of cell-based viability or proliferation workflows. This scenario-based guide covers mechanism, DMSO compatibility, storage, controls, data interpretation, and practical vendor-selection criteria.
-
Vitamin Repurposing Against SARS-CoV-2: Docking Insights
2026-09-02
Eskandari’s 2022 study used molecular docking and molecular dynamics to evaluate vitamin-derived natural compounds against SARS-CoV-2 3CLpro and the spike receptor-binding domain. The work highlights a dual-target computational strategy for antiviral therapeutics research while showing why predicted binding must be followed by biochemical and cellular validation.